DYRK1A Gene Mental Retardation Autosomal Dominant Type 7 NGS Genetic DNA Test
Comprehensive Genetic Testing for Intellectual Disability
The DYRK1A Gene Mental Retardation Autosomal Dominant Type 7 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced next-generation sequencing test specifically targets the DYRK1A gene, which plays a critical role in brain development and cognitive function. Mutations in this gene are responsible for autosomal dominant mental retardation type 7, a condition characterized by intellectual disability, developmental delays, and various neurological manifestations.
What This Test Measures and Detects
Our comprehensive NGS genetic test analyzes the entire DYRK1A gene sequence to identify pathogenic variants including:
- Point mutations and single nucleotide variants
- Small insertions and deletions (indels)
- Copy number variations affecting the DYRK1A gene
- Frameshift mutations that disrupt protein function
- Missense and nonsense mutations impacting gene expression
Who Should Consider This Test
This genetic test is recommended for individuals presenting with:
- Unexplained intellectual disability or developmental delays
- Microcephaly (small head circumference)
- Speech and language impairments
- Autism spectrum features
- Seizures or epilepsy
- Distinctive facial features associated with DYRK1A syndrome
- Family history of autosomal dominant intellectual disability
- Children with global developmental delay
Clinical Benefits of DYRK1A Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages:
- Definitive Diagnosis: Confirms or rules out DYRK1A-related mental retardation
- Family Planning Guidance: Enables informed reproductive decisions
- Personalized Management: Guides appropriate educational and therapeutic interventions
- Prognostic Information: Helps understand the condition’s progression
- Genetic Counseling: Provides family risk assessment and recurrence probability
- Research Contribution: Advances understanding of neurological genetic disorders
Understanding Your Test Results
Our genetic specialists provide comprehensive result interpretation:
- Positive Result: Identifies a pathogenic DYRK1A mutation confirming diagnosis
- Negative Result: No disease-causing mutation detected in DYRK1A gene
- Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact
- Carrier Status: Determines inheritance patterns for family members
All results include detailed genetic counseling to help you understand the implications and next steps.
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have diagnostic centers across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.
Take Control of Your Genetic Health Today
Don’t let uncertainty about neurological conditions affect your family’s future. Our DYRK1A genetic test provides the clarity needed for informed healthcare decisions. With results in 3-4 weeks and comprehensive genetic counseling included, you’ll gain valuable insights into your genetic health.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling team.
Our experienced neurologists and genetic specialists are ready to help you understand your genetic profile and provide the expert guidance you need for managing neurological genetic conditions.
